5-Amino-1MQ Research Guide (Preclinical Overview)
Nicotinamide N-methyltransferase (NNMT) plays a pivotal regulatory role in cellular energy homeostasis, methyl group allocation, and mitochondrial efficiency. This scientific overview examines 5-Amino-1MQ, a selective, small-molecule NNMT inhibitor evaluated in preclinical models for its ability to modulate intracellular NAD+ pools, elevate metabolic rate, and influence adipocyte physiology.
Quick answer
Nicotinamide N-methyltransferase (NNMT) plays a pivotal regulatory role in cellular energy homeostasis, methyl group allocation, and mitochondrial efficiency. This scientific overview examines 5-Amino-1MQ, a selective, small-molecule NNMT inhibitor evaluated in preclinical models for its ability to modulate intracellular NAD+ pools, elevate metabolic rate, and influence adipocyte physiology.
Key takeaways
- [5-Amino-1MQ](/research-peptides/5-amino-1mq) (5-amino-1-methylquinolinium) is a membrane-permeable, small-molecule derivative of quinoline designed to target cytosolic enzymes involved in nutrient sensing and epigenetic regulation.
- Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme primarily expressed in metabolic tissues, including white adipose tissue (WAT), liver, and skeletal muscle.
- The primary biochemical rationale for investigating [5-Amino-1MQ](/research-peptides/5-amino-1mq) centers on the salvage pathway of nicotinamide adenine dinucleotide ([NAD+](/research-peptides/nad-plus)).
- Mitochondrial density and oxidative phosphorylation efficiency directly depend on intracellular [NAD+](/research-peptides/nad-plus)/NADH ratios.
1. Structural Chemistry and Molecular Profile of 5-Amino-1MQ
5-Amino-1MQ (5-amino-1-methylquinolinium) is a membrane-permeable, small-molecule derivative of quinoline designed to target cytosolic enzymes involved in nutrient sensing and epigenetic regulation. Structurally categorized as a quinolinium cation, the compound possesses a targeted molecular weight and electronic charge distribution optimized for active site binding within cytosolic methyltransferases.
Unlike large peptide chains, 5-Amino-1MQ operates as a direct chemical inhibitor. Preclinical evaluations demonstrate that its selective spatial structure fits into the substrate-binding pocket of cytosolic enzymes without non-specifically perturbing adjacent kinase cascades. Laboratories utilizing high-purity chemical reagents source this agent through our specialized 5-Amino-1MQ chemical standard selection to ensure reproducible kinetic assays in cell culture and animal tissue models.
2. Enzymatic Target: The Role of Nicotinamide N-Methyltransferase (NNMT)
Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme primarily expressed in metabolic tissues, including white adipose tissue (WAT), liver, and skeletal muscle. NNMT catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), producing 1-methylnicotinamide (1-MNA) and S-adenosylhomocysteine (SAH). Because 1-MNA is excreted and cannot be directly recycled back into the salvage pathway, high NNMT expression effectively drains the intracellular pool of nicotinamide.
In metabolic research, overactivation of NNMT is strongly correlated with reduced cellular energy expenditure, compromised mitochondrial respiration, and altered epigenetic methylation. Research using an explicit NNMT inhibitor research framework explores how blunting this specific enzymatic pathway alters energy sensing, substrate flux, and cellular adaptation under high-nutrient or high-fat conditions.
3. Mechanism of Action: NAD+ Salvage and Methyl Group Preservation
The primary biochemical rationale for investigating 5-Amino-1MQ centers on the salvage pathway of nicotinamide adenine dinucleotide (NAD+). NAD+ is an essential coenzyme required for mitochondrial electron transport, sirtuin deacetylase activity, and poly(ADP-ribose) polymerase (PARP) repair mechanisms. By inhibiting NNMT activity, 5-Amino-1MQ prevents the irreversible methylative clearance of nicotinamide.
In vitro models demonstrate that retaining intracellular nicotinamide preserves substrate availability for Nicotinamide Phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in the primary NAD+ salvage loop. Consequently, preclinical assays report elevated intracellular NAD+ concentrations without requiring exogenous NAD+ precursors. For detailed biochemical diagrams and pathway analyses, researchers can consult our NAD+ pathway research documentation within the portal.
4. Mitochondrial Output and Cellular Energetics
Mitochondrial density and oxidative phosphorylation efficiency directly depend on intracellular NAD+/NADH ratios. When NNMT activity is blunted by 5-Amino-1MQ in cultured myocytes and mature adipocytes, researchers observe a marked upregulation in sirtuin 1 (SIRT1) signaling. SIRT1 activation subsequently promotes the deacetylation of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), a master regulator of mitochondrial biogenesis.
Preclinical respirometry assays (e.g., Seahorse XF analysis) reveal that cells treated with 5-Amino-1MQ exhibit increased basal respiration, elevated spare respiratory capacity, and enhanced ATP production rates. These findings indicate that NNMT suppression alters baseline metabolic flux, making it a focal point in mitochondrial output studies looking at metabolic decline and oxidative phosphorylation capacities.
5. Preclinical Research in Fat-Metabolism and Adipocyte Dynamics
In rodent models of diet-induced obesity, high-fat diets trigger significant upregulation of NNMT in white adipose tissue, leading to diminished energy expenditure and accelerated lipid accumulation. In vivo administration of 5-Amino-1MQ in these animal models yielded notable physiological changes, including reduced adipocyte hypertrophy, decreased fat mass accumulation, and enhanced systemic insulin sensitivity—without modifying caloric intake.
Gene expression profiling of adipose tissue harvested from treated animal subjects shows a down-regulation of lipogenic markers alongside a concomitant up-regulation of genes responsible for fatty acid beta-oxidation and uncoupling protein 1 (UCP1) expression. These data suggest that 5-Amino-1MQ facilitates a phenotypic shift in adipocytes from energy storage toward active lipid oxidation.
6. Comparative Analysis: 5-Amino-1MQ vs. Parallel Metabolic Regulators
To contextualize the performance of 5-Amino-1MQ within metabolic research, investigators often compare its mechanism against direct AMP-activated protein kinase (AMPK) activators and mitochondrial-derived peptides. While 5-Amino-1MQ acts upstream by inhibiting methyl transfer and salvaging NAD+, agents like the AICAR research compound directly activate AMPK to mimic energy deprivation states. Similarly, PPAR-delta agonists and Rev-ErbA agonists such as the SR9009 research monograph compounds modulate circadian metabolic flux and endurance pathways through distinct nuclear receptor signaling cascades.
Furthermore, mitochondrial-derived peptides like the MOTS-c peptide target nuclear gene expression to regulate insulin sensitivity and metabolic homeostasis. Combining or comparing these molecules in controlled cellular systems allows research laboratories to map overlapping versus distinct pathways governing lipid catabolism, mitochondrial density, and cellular survival mechanisms.
7. Laboratory Reconstitution, Solubility, and Assay Preparation
For valid in vitro experimentation, 5-Amino-1MQ must be dissolved and handled according to standardized chemical protocols. The standard solid form is a high-purity crystalline salt. It exhibits robust solubility in dimethyl sulfoxide (DMSO) up to concentrations of 20–50 mg/mL, while aqueous solubility (e.g., in phosphate-buffered saline, pH 7.2) may require mild warming or sonication depending on final target molarities.
Stock solutions should be prepared in sterile, anhydrous solvents under inert atmosphere hoods to prevent moisture absorption. Solutions dissolved in pure DMSO can be aliquoted into single-use microcentrifuge tubes and stored at -80°C to minimize freeze-thaw degradation cycles. Investigators should ensure that solvent vehicle controls (e.g., final DMSO concentration < 0.1% v/v in cell culture media) are strictly maintained across experimental and control wells.
8. Analytical Verification and Quality Standards
Due to the sensitive nature of metabolic and epigenetic research, batch-to-batch consistency and chemical purity are mandatory to prevent confounding assay outcomes. Off-target enzymatic inhibition or cell toxicity often stems from residual heavy metals, unreacted synthesis intermediates, or degradation byproducts. PX1 Research subjects every lot of 5-Amino-1MQ to stringent chemical validation.
Analytical protocols include high-performance liquid chromatography (HPLC) paired with mass spectrometry (MS) to confirm identity and quantify purity (>98%). Furthermore, specialized endotoxin and micro-impurity testing is performed to ensure compliance for in vitro cell culture and animal model administration. Laboratory directors can access complete testing methodologies via our HPLC purity analysis protocols resource.
9. Institutional Sourcing and Supply Chain Considerations
PX1 Research operates dedicated manufacturing and distribution channels within the USA, shipping directly from facilities in California and Arizona. Orders placed Monday through Friday before cut-off times qualify for same-day dispatch, guaranteeing that critical research timelines are maintained without logistical delay.
All compounds are synthesized in state-of-the-art facilities compliant with GMP guidelines and analyzed by independent, ISO 17025 accredited laboratories. Principal investigators and university purchasing agents requiring bulk quantities, lot-reserved batches, or specialized custom packaging options are encouraged to explore our dedicated institutional wholesale accounts program or review our central PX1 scientific research hub.
Frequently Asked Questions
What is the primary molecular target of 5-Amino-1MQ in preclinical models?
5-Amino-1MQ is a selective, small-molecule inhibitor of Nicotinamide N-Methyltransferase (NNMT), a cytosolic enzyme involved in methyl group allocation and nicotinamide metabolism.
How does NNMT inhibition elevate intracellular NAD+ levels?
By inhibiting NNMT, 5-Amino-1MQ prevents the methylation of nicotinamide into 1-methylnicotinamide (1-MNA). This retains nicotinamide inside the cell, allowing it to re-enter the NAD+ salvage pathway via the NAMPT enzyme.
What purity metrics does PX1 Research provide for 5-Amino-1MQ?
Every lot of 5-Amino-1MQ from PX1 Research undergoes rigorous testing via HPLC and Mass Spectrometry, ensuring greater than 98% purity, confirmed molecular weight, and strict endotoxin compliance.
What are the standard solubility options for in vitro 5-Amino-1MQ preparation?
5-Amino-1MQ is readily soluble in DMSO at concentrations up to 50 mg/mL. Stock solutions should be prepared using anhydrous DMSO and diluted into culture media to maintain vehicle concentrations below 0.1% v/v.
How should dry and reconstituted 5-Amino-1MQ be stored in the laboratory?
Lyophilized powder should be stored desiccated at -20°C for long-term stability. Reconstituted stock solutions in DMSO should be aliquoted and maintained at -80°C, avoiding repeated freeze-thaw cycles.
Is 5-Amino-1MQ suitable for human consumption or therapeutic administration?
No. 5-Amino-1MQ is strictly produced and distributed as a research chemical for laboratory research use only. It is not intended for human or animal therapeutic use, clinical administration, or diagnostic procedures.
How does 5-Amino-1MQ compare to metabolic research peptides like MOTS-c?
5-Amino-1MQ is a small-molecule enzyme inhibitor targeting the NNMT/NAD+ salvage pathway, whereas MOTS-c is a mitochondrial-derived peptide that targets nuclear transcription factors to modulate metabolic flexibility.
Where are PX1 Research compounds synthesized and shipped from?
PX1 Research compounds are synthesized in the USA in GMP-compliant facilities and dispatched directly from distribution hubs in California and Arizona, featuring same-day shipping on orders placed Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.